Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 July 2022 | Story Lacea Loader

The Council of the University of the Free State (UFS) approved the lifting of the institution’s COVID-19 Regulations and Required Vaccination Policy with immediate effect.

“Since the declaration by the Government on 22 June 2022 that the COVID-19 regulations will be repealed, the UFS has conducted a risk assessment to determine the risk of exposure to staff and students. From the assessment, it was clear that the university’s COVID-19 infections are currently a low risk,” said Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.

Factors that contributed to this low risk include the following:

  • No COVID-19 positive cases among UFS staff and students have been reported in the past month.
  • The high number of vaccinations among UFS stakeholders. In addition, the current national immunity level of the total South African population is high.
  • Certain faculties and postgraduate students are currently proceeding with hybrid/online learning, which minimises the risk of possible COVID-19 infections on the university’s three campuses.
  • In its correspondence of 23 June 2022, the UFS urged all staff and students to continue wearing masks should they have comorbidities and/or symptoms of illness, thus safeguarding other stakeholders.

“We believe that COVID-19 no longer poses an immediate threat to the safety of our staff and students, and that the pandemic is at a stage where they should take responsibility for their own safety. This can be mainly ascribed to the success of the implementation of the policy. Staff and students who still wish to wear masks are urged to do so at their own discretion. Those who have not yet been vaccinated against the virus and have no

known condition preventing them from doing so, are advised to get vaccinated for their own safety and protection,” said Prof Petersen.

The UFS COVID-19 Regulations and Required Vaccination Policy was approved by the University Council on 26 November 2021 and implemented on 6 December 2021. The university commenced restricting unvaccinated individuals from accessing its campuses as of 14 February 2022.

“If the national regulatory environment with respect to COVID-19 is changing to such an extent that the policy needs to be re-implemented, the university’s executive management will act accordingly, and hence the COVID-19 Regulations and Required Vaccination Policy remains a policy of the university as approved by the UFS Council on 26 November 2021.” said Prof Petersen.

 

Uplifting of the COVID-19 vaccination policy - mitigation strategies of the University of the Free State.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept